These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28131652)

  • 1. Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone.
    Wu L; Chen J; Wu Y; Zhang B; Cai X; Zhang Z; Wang Y; Si L; Xu H; Zheng Y; Zhang C; Liang C; Li J; Zhang L; Zhang Q; Zhou D
    J Control Release; 2017 Mar; 249():84-93. PubMed ID: 28131652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone.
    Wu L; Ji S; Hu T
    Mol Pharm; 2015 May; 12(5):1402-11. PubMed ID: 25849255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification.
    Karbasian M; Kouchakzadeh H; Anamaghi PN; Sefidbakht Y
    Int J Pharm; 2019 Feb; 557():9-17. PubMed ID: 30576790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of next generation of therapeutic IFN-α2b via genetic code expansion.
    Zhang B; Xu H; Chen J; Zheng Y; Wu Y; Si L; Wu L; Zhang C; Xia G; Zhang L; Zhou D
    Acta Biomater; 2015 Jun; 19():100-11. PubMed ID: 25769229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
    Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ
    Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
    Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH
    Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
    Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
    Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.
    Tamshen K; Wang Y; Jamieson SMF; Perry JK; Maynard HD
    Bioconjug Chem; 2020 Sep; 31(9):2179-2190. PubMed ID: 32786367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients.
    Myler HA; McVay S; Kratzsch J
    J Pharmacol Toxicol Methods; 2010; 61(2):92-7. PubMed ID: 20044010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new PEG-beta-alanine active derivative for releasable protein conjugation.
    Pasut G; Mero A; Caboi F; Scaramuzza S; Sollai L; Veronese FM
    Bioconjug Chem; 2008 Dec; 19(12):2427-31. PubMed ID: 19053302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins.
    Mirzaei H; Kazemi B; Bandehpour M; Shoari A; Asgary V; Ardestani MS; Madadkar-Sobhani A; Cohan RA
    Drug Des Devel Ther; 2016; 10():1193-200. PubMed ID: 27042012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity.
    Huang Z; Ni C; Chu Y; Wang S; Yang S; Wu X; Wang X; Li X; Feng W; Lin S
    J Biotechnol; 2009 Jul; 142(3-4):242-9. PubMed ID: 19477206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats.
    Zhang ZX; Liu YK; Pan H; Pan L; Zhang Q; Su HM; Zhao QL; Li H; He C
    Growth Horm IGF Res; 2012 Feb; 22(1):30-5. PubMed ID: 22257554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone.
    Mero A; Schiavon M; Veronese FM; Pasut G
    J Control Release; 2011 Aug; 154(1):27-34. PubMed ID: 21565230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.